144 related articles for article (PubMed ID: 23241496)
1. Clinical and multiple gene expression variables in survival analysis of breast cancer: analysis with the hypertabastic survival model.
Tabatabai MA; Eby WM; Nimeh N; Li H; Singh KP
BMC Med Genomics; 2012 Dec; 5():63. PubMed ID: 23241496
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hypertabastic survival model with other unimodal hazard rate functions using a goodness-of-fit test.
Tahir MR; Tran QX; Nikulin MS
Stat Med; 2017 May; 36(12):1936-1945. PubMed ID: 28173610
[TBL] [Abstract][Full Text] [Related]
3. Application of Cox and Parametric Survival Models to Assess Social Determinants of Health Affecting Three-Year Survival of Breast Cancer Patients.
Mohseny M; Amanpour F; Mosavi-Jarrahi A; Jafari H; Moradi-Joo M; Davoudi Monfared E
Asian Pac J Cancer Prev; 2016; 17(S3):311-6. PubMed ID: 27165244
[TBL] [Abstract][Full Text] [Related]
4. Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis.
Zhang Y; Yang W; Li D; Yang JY; Guan R; Yang MQ
BMC Med Genomics; 2018 Nov; 11(Suppl 5):104. PubMed ID: 30454048
[TBL] [Abstract][Full Text] [Related]
5. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
[TBL] [Abstract][Full Text] [Related]
6. Combining gene signatures improves prediction of breast cancer survival.
Zhao X; Rødland EA; Sørlie T; Naume B; Langerød A; Frigessi A; Kristensen VN; Børresen-Dale AL; Lingjærde OC
PLoS One; 2011 Mar; 6(3):e17845. PubMed ID: 21423775
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population- based data from British Columbia, Canada.
Abadi A; Saadat S; Yavari P; Bajdik C; Jalili P
Asian Pac J Cancer Prev; 2011; 12(11):3113-6. PubMed ID: 22393999
[TBL] [Abstract][Full Text] [Related]
8. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
9. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
Royston P; Parmar MK
Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Weibull and Lognormal Cure Models with Cox in the Survival Analysis Of Breast Cancer Patients in Rafsanjan.
Hoseini M; Bahrampour A; Mirzaee M
J Res Health Sci; 2017 Feb; 17(1):e00369. PubMed ID: 28413171
[TBL] [Abstract][Full Text] [Related]
11. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
12. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
13. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
Zerdes I; Sifakis EG; Matikas A; Chrétien S; Tobin NP; Hartman J; Rassidakis GZ; Bergh J; Foukakis T
Mol Oncol; 2020 May; 14(5):951-963. PubMed ID: 32115850
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
[TBL] [Abstract][Full Text] [Related]
16. Statistical estimates from black non-Hispanic female breast cancer data.
Khan HM; Ibrahimou B; Saxena A; Gabbidon K; Abdool-Ghany F; Ramamoorthy V; Ullah D; Stewart TS
Asian Pac J Cancer Prev; 2014; 15(19):8371-6. PubMed ID: 25339031
[TBL] [Abstract][Full Text] [Related]
17. Impact of triple negative phenotype on breast cancer prognosis.
Kaplan HG; Malmgren JA
Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
[TBL] [Abstract][Full Text] [Related]
18. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival in patients with breast cancer referred to Cancer Research Center in Iran.
Baghestani AR; Shahmirzalou P; Zayeri F; Akbari ME; Hadizadeh M
Asian Pac J Cancer Prev; 2015; 16(12):5081-4. PubMed ID: 26163645
[TBL] [Abstract][Full Text] [Related]
20. Prognostic stromal gene signatures in breast cancer.
Winslow S; Leandersson K; Edsjö A; Larsson C
Breast Cancer Res; 2015 Feb; 17(1):23. PubMed ID: 25848820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
